At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 31, 2026 at 16:21 ET
Two top executives at Cytokinetics, including CEO Robert Blum, sold shares in a coordinated 7-day window, generating $736,000 in total proceeds. The sales represent a modest but notable insider selling cluster, with both executives liquidating holdings at market prices.
- CEO Robert Blum sold 7,500 shares for $499,725 in open-market transaction on April 1, 2026.
- EVP Andrew Callos sold 3,639 shares for $236,535 on March 31, 2026.
- Total cluster value: $736,260 in open-market sales by C-suite executives.
- Sales represent 0.009% of Cytokinetics' $8.1B market cap, modest in scale but concerning due to executive rank.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access